Proteovant Therapeutics
- Drew Fromkin
Drew has 30+ years of leadership in public & private healthcare companies. He serves as Vant Portfolio Operating Partner for Roivant Sciences, Inc. (ROIV) and on the board of Immunovant, Inc. (IMVT).
Org chart
Sign up to view 8 direct reports
Get started